ClinicalTrials.gov record
Completed Phase 3 Interventional

The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs

ClinicalTrials.gov ID: NCT00002368

Public ClinicalTrials.gov record NCT00002368. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An International, Double Blind, Randomized, Phase III Study to Evaluate the Tolerance, Safety, and Effectiveness of Viramune (Nevirapine) in Preventing Clinical AIDS Progression Events or Death When Used in Combination With Lamivudine (3TC) and Stable (>= 4 Weeks) Background Nucleoside Therapy

Study identification

NCT ID
NCT00002368
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
2,000 participants

Conditions and interventions

Conditions

Interventions

  • Lamivudine Drug
  • Nevirapine Drug

Drug

Eligibility (public fields only)

Age range
13 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
53
U.S. states
25
U.S. cities
44
Facility City State ZIP Site status
Drug Research and Analysis Corp Montgomery Alabama 36104
Dr G Michael Wool Los Angeles California 90067
UCLA School of Medicine / Ctr for Research and Education Los Angeles California 900951793
AIDS Research Ctr / Palo Alto VA Health Care System Palo Alto California 94304
AIDS Community Research Consortium Redwood City California 94063
ViRx Inc San Francisco California 94109
San Francisco Gen Hosp / UCSF AIDS Program San Francisco California 94110
Harbor - UCLA Med Ctr Torrance California 90502
Infectious Disease Specialists Colorado Springs Colorado 80903
Denver Public Health Denver Colorado 80204
Dr Miguel Mogyoros / Clinical Research Dept Denver Colorado 80205
Wilmington Hosp Wilmington Delaware 19801
Novum Inc Washington D.C. District of Columbia 20037
Anthony LaMarca Fort Lauderdale Florida 33308
North Broward Hosp District Fort Lauderdale Florida 33316
Dr Robert Schwartz Fort Myers Florida 33901
McGregor Clinic / Lee County Public Health Unit Fort Myers Florida 33901
P Andrew Coley Jacksonville Florida 32216
Goodgame Med Group Maitland Florida 32751
Infectious Disease Research Institute Inc Tampa Florida 33614
Palm Beach Research Ctr West Palm Beach Florida 33409
Dr John Pottage Chicago Illinois 60610
Northwestern Univ / Division of Infectious Diseases Chicago Illinois 60611
Rush Presbyterian / Saint Luke's Med Ctr / Infect Dis Chicago Illinois 60612
Indiana Univ Med School Indianapolis Indiana 46202
Dr Daniel H Gervich Des Moines Iowa 50325
Univ of Iowa Iowa City Iowa 52242
Univ of Kentucky Med Cntr / Dept of Med / Div of ID Lexington Kentucky 40563
Med Research Ctr New Orleans Louisiana 70112
New England Med Ctr Boston Massachusetts 02111
Beth Israel Hosp / Virology Research Clinic Boston Massachusetts 02215
New England Deaconess Hosp Boston Massachusetts 02215
International Medicine and Infectious Disease Minneapolis Minnesota 55407
Trinity Lutheran Hosp / HIV Program Kansas City Missouri 64108
Infectious Disease Associates of Central New Jersey Somerville New Jersey 08876
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215
Dr David Kaufman New York New York 10014
Saint Vincent Med Ctr Staten Island New York 10310
Associates in Med and Mental Health Tulsa Oklahoma 74114
The Research and Education Group Portland Oregon 97210
Hershey Med Ctr / Dept of Med / Div of Hematology Hershey Pennsylvania 17033
Univ of Pennsylvania / Division of Infectious Diseases Philadelphia Pennsylvania 19104
Novum Inc Pittsburgh Pennsylvania 152063817
Omega Med Research Providence Rhode Island 02907
Med Univ of South Carolina / Div of Infect Dis Charleston South Carolina 29425
Dr Alfred Burnside Columbia South Carolina 29206
Dr Susie Sargent Memphis Tennessee 38163
Nelson Tebedo Health Resource Ctr Dallas Texas 75219
Univ of Texas Med Branch / Div of Infectious Dis Galveston Texas 775550835
Houston Clinical Research Network / Div of Montrose Clinic Houston Texas 77006
Walter Gaman Irving Texas 75038
Hampton Roads Med Specialists Hampton Virginia 23666
Advanced Research Management Seattle Washington 981225314

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002368, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002368 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →